SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-004469
Filing Date
2015-12-10
Accepted
2015-12-10 16:31:14
Documents
11
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-103115.htm 10-Q 383554
2 COMPREHENSIVE ARTICLES AND CERTIFICATES OF INCORPORATION peregrine_10q-ex0301.htm EX-3.1 435633
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER peregrine_10q-ex3101.htm EX-31.1 7573
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_10q-ex3102.htm EX-31.2 7577
5 CERTIFICATION peregrine_10q-ex32.htm EX-32 4943
  Complete submission text file 0001019687-15-004469.txt   3214575

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pphm-20151031.xml EX-101.INS 612349
7 XBRL SCHEMA FILE pphm-20151031.xsd EX-101.SCH 29656
8 XBRL CALCULATION FILE pphm-20151031_cal.xml EX-101.CAL 49366
9 XBRL DEFINITION FILE pphm-20151031_def.xml EX-101.DEF 76043
10 XBRL LABEL FILE pphm-20151031_lab.xml EX-101.LAB 195151
11 XBRL PRESENTATION FILE pphm-20151031_pre.xml EX-101.PRE 164649
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 151281201
SIC: 2834 Pharmaceutical Preparations